Medirom Healthcare Technologies Inc. current report, Q3 FY2022

Medirom Healthcare Technologies Inc. — Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed July 1, 2022, covers the month of July 2022 and reports a Nasdaq continued-listing compliance notification. The company is a foreign private issuer headquartered in Tokyo, Japan, and files annual reports on Form 20-F.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating-performance metrics.

Material Changes Versus the Prior Comparable Period

On June 29, 2022, Nasdaq notified the company that it was not in compliance with Nasdaq Capital Market Listing Rule 5550(b)(2), which requires a minimum market value of publicly held shares of US$35 million. The deficiency was based on the company’s market value during the 30-business-day period from May 9 through June 28, 2022.

Outlook, Risks, Contingencies, and Unusual Items

  • The notification does not immediately affect the company’s Nasdaq Capital Market listing.
  • The company has until December 27, 2022, a 180-calendar-day compliance period, to regain compliance.
  • The filing does not describe the specific actions management plans to take to restore compliance or the likelihood of doing so.
  • Failure to regain compliance could result in further Nasdaq action, including potential delisting, subject to applicable rules and procedures.
  • The filing includes customary forward-looking statement warnings regarding assumptions, uncertainties, and factors beyond the company’s control.

Investor Verification Checklist

  • Verify whether the company regained compliance with Nasdaq’s US$35 million minimum market value requirement by December 27, 2022.
  • Review subsequent SEC filings and Nasdaq notices for any extension, appeal, hearing, or delisting determination.
  • Assess the company’s market capitalization, share price, publicly held shares, and any corporate actions that could affect listing compliance.
  • Review the company’s financial statements separately, as this Form 6-K does not provide financial results or liquidity information.